Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter, but their bottom lines diverged...
Search results for "second quarter"
Samsung Biologics Posts 586.4 Billion Won Q2 Profit, But Labor Uncertainty Looms
Samsung Biologics reported second-quarter revenue in the 1. 3 trillion won range this year, a 30% increase from the same period last year.
The AI-Powered Future of K-Beauty: APR Bets Big on Smart Hardware and Custom Routines
K-beauty’s growth engine is rapidly expanding from traditional cosmetics into at-home beauty devices.
Beyond Cosmetics: Foreign Tourists Stock Up on Korean OTC Skin Ointments
Search TikTok for "must-buy items at Korean pharmacies," and a steady stream of video recommendations fills the screen.
AI Generates and Self-Checks Specialist Study Materials—Yet 1% Still Contain Critical Errors
Artificial intelligence can now generate study materials for medical specialist board exams and run automated checks...
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
Celltrion Chairman Seo Jung-jin Forgoes Summer Vacation for Global Business Tour Targeting Record Second Half
Celltrion Group Chairman Seo Jung-jin will forgo his summer vacation this August to embark on an intensive overseas...
Sales Rise 11%, but Chong Kun Dang’s Q2 Operating Profit Slips 10%
Chong Kun Dang posted higher sales in the second quarter of this year, but its operating profit fell 10% from a year...
Eli Lilly Licensing Deal Surge: Hanmi Pharmaceutical’s Q2 Operating Profit Jumps 117%
Hanmi Pharmaceutical posted a sharp profit surge in the second quarter of this year, buoyed by a major...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...